Volpara Health Technologies Limited
ASX:VHT.AX
1.145 (AUD) • At close May 3, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2018 Q4 | 2017 Q4 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 18.341 | 16.662 | 15.246 | 13.015 | 11.6 | 9.609 | 8.832 | 5.493 | 6.477 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 4.258 | 3.783 | 3.622 | 3.44 | 3.11 | 2.373 | 2.092 | 2.748 | 0.729 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 14.083 | 12.879 | 11.624 | 9.575 | 8.49 | 7.236 | 6.74 | 2.745 | 5.748 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.768 | 0.773 | 0.762 | 0.736 | 0.732 | 0.753 | 0.763 | 0.5 | 0.887 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 7.693 | 7.398 | 8.698 | 8.623 | 7.25 | 6.498 | 6.735 | 6.034 | 4.334 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.913 | 10.412 | 9.8 | 8.017 | 12.409 | 10.424 | 9.691 | 11.869 | 9.492 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 18.605 | 17.81 | 18.498 | 16.639 | 19.659 | 16.921 | 16.427 | 17.903 | 13.827 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income
| -4.522 | -4.931 | -6.874 | -7.064 | -11.169 | -9.685 | -9.687 | -15.159 | -8.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio
| -0.247 | -0.296 | -0.451 | -0.543 | -0.963 | -1.008 | -1.097 | -2.76 | -1.247 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.089 | -0.43 | 1.864 | 0.273 | 2.736 | 0.892 | 0.785 | 1.536 | 0.482 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -4.611 | -5.361 | -5.01 | -6.792 | -8.433 | -8.793 | -8.902 | -13.623 | -7.597 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -0.251 | -0.322 | -0.329 | -0.522 | -0.727 | -0.915 | -1.008 | -2.48 | -1.173 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.535 | -1.211 | -0.237 | 0.694 | -0.422 | -0.735 | -0.63 | -1.829 | -0.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -4.076 | -4.15 | -4.773 | -7.485 | -8.011 | -8.058 | -8.272 | -11.794 | -7.578 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio
| -0.222 | -0.249 | -0.313 | -0.575 | -0.691 | -0.839 | -0.937 | -2.147 | -1.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.016 | -0.016 | -0.019 | -0.03 | -0.032 | -0.032 | -0.034 | -0.054 | -0.038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS Diluted
| -0.016 | -0.016 | -0.019 | -0.03 | -0.032 | -0.032 | -0.034 | -0.054 | -0.038 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA
| -1.811 | -2.306 | -4.501 | -4.786 | -9.056 | -8.162 | -8.325 | -13.366 | -7.737 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA Ratio
| -0.099 | -0.138 | -0.295 | -0.368 | -0.781 | -0.849 | -0.943 | -2.433 | -1.195 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |